Janice Natasha C. Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janice Natasha C. Ng has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Rungsima Wanitphakdeedecha
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok 10700, Thailand
9 shared publications - Chadakan Yan
Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
6 shared publications Sasima Eimpunth
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, THAILAND
3 shared publicationsTatchalerm Sudhipongpracha
College of Interdisciplinary Studies Thammasat University Bangkok Thailand
3 shared publications- Woraphong Manuskiatti
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, THAILAND
3 shared publications Tatre Jantarakolica
Faculty of Economics Thammasat University Bangkok Thailand
2 shared publications
Latest Publications
- 30 January 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (2) , 698-706
Efficacy of handheld iontophoresis device in enhancing transdermal vitamin C delivery: A split‐face clinical trial
Background The stratum corneum of the epidermis is the principal barrier in topical drug delivery. Currently, iontophoresis is incorporated in dermatology management to increase transdermal drug delivery. Objective To evaluate the efficacy and safety of handheld iontophoresis device in enhancing transdermal vitamin C delivery. Methods This was a prospective split-face clinical trial with a total of 24 subjects, who presented with photoaging skin. All subjects were treated with the handheld iontophoresis device on the left side of their face, twice a week for 8 weeks. Primary outcomes were the improvement in pore tightening and skin hydration. Evaluations were done at baseline, 2-, 4-, 6-, and 8-week follow-up. Subjects' self-improvement scores and adverse reactions were also recorded. Results Out of 24 subjects, 17 (70.8%) completed the study protocol. Pore tightening in the iontophoresis group had significant improvement at 2- and 8-week follow-up when compared to the baseline (p = 0.019 and 0.026). Skin hydration on the iontophoresis group improved significantly at 4-week follow-up when compared to the baseline (p = 0.024). In the iontophoresis group, an image of the skin captured using Visioscan® showed improvement of skin texture and pore tightening at 8-week follow-up. Majority of the subjects in the iontophoresis group scored good improvement at 2-, 4-, and 6-week follow-up (41.7%, 29.2%, and 45.8%) when compared to the baseline. No adverse reactions were recorded. Conclusion The handheld iontophoresis device is safe and can be used as an adjunctive home treatment in enhancing transdermal vitamin C delivery.
- 30 January 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (2) , 698-706
Efficacy of handheld iontophoresis device in enhancing transdermal vitamin C delivery: A split‐face clinical trial
Background The stratum corneum of the epidermis is the principal barrier in topical drug delivery. Currently, iontophoresis is incorporated in dermatology management to increase transdermal drug delivery. Objective To evaluate the efficacy and safety of handheld iontophoresis device in enhancing transdermal vitamin C delivery. Methods This was a prospective split-face clinical trial with a total of 24 subjects, who presented with photoaging skin. All subjects were treated with the handheld iontophoresis device on the left side of their face, twice a week for 8 weeks. Primary outcomes were the improvement in pore tightening and skin hydration. Evaluations were done at baseline, 2-, 4-, 6-, and 8-week follow-up. Subjects' self-improvement scores and adverse reactions were also recorded. Results Out of 24 subjects, 17 (70.8%) completed the study protocol. Pore tightening in the iontophoresis group had significant improvement at 2- and 8-week follow-up when compared to the baseline (p = 0.019 and 0.026). Skin hydration on the iontophoresis group improved significantly at 4-week follow-up when compared to the baseline (p = 0.024). In the iontophoresis group, an image of the skin captured using Visioscan® showed improvement of skin texture and pore tightening at 8-week follow-up. Majority of the subjects in the iontophoresis group scored good improvement at 2-, 4-, and 6-week follow-up (41.7%, 29.2%, and 45.8%) when compared to the baseline. No adverse reactions were recorded. Conclusion The handheld iontophoresis device is safe and can be used as an adjunctive home treatment in enhancing transdermal vitamin C delivery.
- 17 January 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (3) , 998-1003
Price decomposition of laser treatment for port‐wine stain using the hedonic pricing model
Background Port-wine stain (PWS) is a congenital capillary malformation associated with negative effects on the quality of life and psychological health of the patients. Pulsed dye laser (PDL) is the current treatment of choice for PWS; however, there is little information on the factors determining the treatment price of PWS. We aim to explore the factors determining the treatment price of PWS. Methods Data were collected through telephone surveys and self-reported questionnaires from hospitals, chain clinics, and doctor's offices that offered PWS treatment from February 1 to March 30, 2021. Data were analyzed by descriptive statistics and multivariate analysis using a log-linear regression model. Results A total of 104 observations were gathered. The estimated base price of the treatment without any additional features is 98.34 USD. Treatment by dermatologists has an additional charge of 28.41 USD or 28.9%. Some private clinics offer a lower price of 28.7% (or 28.27 USD) by illegally having non-medical doctors perform the treatment. Treatment with 595-nm PDL and 585-nm PDL and 1064-nm Nd:YAG lasers has an additional charge of 34% (or 33.45 USD) and 38% (or 37.41 USD), respectively. The location and type of medical facility can also affect the price of the treatment. Conclusion Many factors determine the base price and shadow price of PWS treatment. Factors determining a higher cost of laser fee includes non-government facilities, location within the capital city, and shopping complexes (high-cost location). Lastly, the type of laser and medical personnel provider can also affect the price of the treatment.
- 17 January 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (3) , 998-1003
Price decomposition of laser treatment for port‐wine stain using the hedonic pricing model
Background Port-wine stain (PWS) is a congenital capillary malformation associated with negative effects on the quality of life and psychological health of the patients. Pulsed dye laser (PDL) is the current treatment of choice for PWS; however, there is little information on the factors determining the treatment price of PWS. We aim to explore the factors determining the treatment price of PWS. Methods Data were collected through telephone surveys and self-reported questionnaires from hospitals, chain clinics, and doctor's offices that offered PWS treatment from February 1 to March 30, 2021. Data were analyzed by descriptive statistics and multivariate analysis using a log-linear regression model. Results A total of 104 observations were gathered. The estimated base price of the treatment without any additional features is 98.34 USD. Treatment by dermatologists has an additional charge of 28.41 USD or 28.9%. Some private clinics offer a lower price of 28.7% (or 28.27 USD) by illegally having non-medical doctors perform the treatment. Treatment with 595-nm PDL and 585-nm PDL and 1064-nm Nd:YAG lasers has an additional charge of 34% (or 33.45 USD) and 38% (or 37.41 USD), respectively. The location and type of medical facility can also affect the price of the treatment. Conclusion Many factors determine the base price and shadow price of PWS treatment. Factors determining a higher cost of laser fee includes non-government facilities, location within the capital city, and shopping complexes (high-cost location). Lastly, the type of laser and medical personnel provider can also affect the price of the treatment.
- Open Access
- 1 June 2021
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 14, 681-690
Quality of Life and Psychological Effects of Port-Wine Stain: A Review of Literature
Introduction: Port-wine stain (PWS) is a congenital malformation that does not resolve spontaneously and can cause a physiological or psychological burden to the patients. At present, most of the studies done on PWS are focused on the treatment rather than the quality of life and psychological effects of the disease. Material and Methods: A comprehensive literature search was done in MEDLINE using PubMed database, Embase®, and Cochrane. All observational studies were included in this review. Results: A total of 17 relevant articles with 2,135 PWS patients were included in this review. There were 36 measurement tools used to assess the quality of life and the psychological effects among PWS patients. The results showed that patients with facial PWS had a significant negative effect on their quality of life and had also suffered from psychological disabilities. The PWS lesion tends to worsen with age and may cause further adaptation problems towards the social environment, especially in children. Conclusion: Early treatment, psychological assistance, and patient support are the key management in improving the quality of life of patients with PWS. Quality of life must be regularly assessed together with the improvement of treatment.
- 1 June 2021
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 14, 681-690
Open AccessQuality of Life and Psychological Effects of Port-Wine Stain: A Review of Literature
Introduction: Port-wine stain (PWS) is a congenital malformation that does not resolve spontaneously and can cause a physiological or psychological burden to the patients. At present, most of the studies done on PWS are focused on the treatment rather than the quality of life and psychological effects of the disease. Material and Methods: A comprehensive literature search was done in MEDLINE using PubMed database, Embase®, and Cochrane. All observational studies were included in this review. Results: A total of 17 relevant articles with 2,135 PWS patients were included in this review. There were 36 measurement tools used to assess the quality of life and the psychological effects among PWS patients. The results showed that patients with facial PWS had a significant negative effect on their quality of life and had also suffered from psychological disabilities. The PWS lesion tends to worsen with age and may cause further adaptation problems towards the social environment, especially in children. Conclusion: Early treatment, psychological assistance, and patient support are the key management in improving the quality of life of patients with PWS. Quality of life must be regularly assessed together with the improvement of treatment.
- 4 May 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (7) , 2203-2210
Self‐stigma and psychosocial burden of patients with port‐wine stain: A systematic review and meta‐analysis
Background: Port‐wine stain (PWS) is a congenital malformation that does not resolve spontaneously and can lead to social and self‐stigma. However, little is known about how PWS affects the patients' quality of life (QoL) and psychosocial well‐being. In this article, we examine the existing empirical evidence on self‐stigma caused by PWS.Methods: A systematic review was done using MEDLINE, PubMed, Embase, and Cochrane databases on January 15, 2021 to retrieve all case reports, cohort studies, and clinical trials written in English. The keywords used in this literature search included port‐wine stain, quality of life, self‐stigma, and social stigma.Results: From the 74 initial records, eight articles were quantitative studies that assessed the QoL and self‐stigma experienced by PWS patients. With regard to perceived stigma or the patients’ understanding of how others think and act toward them, we found that the parents of children with facial PWS tend to have more perceived stigma than the children. For anticipated stigma or expectations of future stigma, young patients with PWS have less or no concern about their skin conditions. In terms of enacted stigma or experiences with discriminatory acts, there were significant differences in the QoL score between patients with facial PWS and those with non‐facial PWS.Conclusion: This study suggests that self‐stigma caused by PWS affects young patients and their parents. The parents in particular tend to suffer more than their children from perceived and anticipated stigma. Psychological support and early treatment can improve the livelihoods of young patients and their parents.
- 4 May 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (7) , 2203-2210
Self‐stigma and psychosocial burden of patients with port‐wine stain: A systematic review and meta‐analysis
Background: Port‐wine stain (PWS) is a congenital malformation that does not resolve spontaneously and can lead to social and self‐stigma. However, little is known about how PWS affects the patients' quality of life (QoL) and psychosocial well‐being. In this article, we examine the existing empirical evidence on self‐stigma caused by PWS.Methods: A systematic review was done using MEDLINE, PubMed, Embase, and Cochrane databases on January 15, 2021 to retrieve all case reports, cohort studies, and clinical trials written in English. The keywords used in this literature search included port‐wine stain, quality of life, self‐stigma, and social stigma.Results: From the 74 initial records, eight articles were quantitative studies that assessed the QoL and self‐stigma experienced by PWS patients. With regard to perceived stigma or the patients’ understanding of how others think and act toward them, we found that the parents of children with facial PWS tend to have more perceived stigma than the children. For anticipated stigma or expectations of future stigma, young patients with PWS have less or no concern about their skin conditions. In terms of enacted stigma or experiences with discriminatory acts, there were significant differences in the QoL score between patients with facial PWS and those with non‐facial PWS.Conclusion: This study suggests that self‐stigma caused by PWS affects young patients and their parents. The parents in particular tend to suffer more than their children from perceived and anticipated stigma. Psychological support and early treatment can improve the livelihoods of young patients and their parents.
- 1 August 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (8) , 1955-1961
The efficacy of macro-focused ultrasound in the treatment of upper facial laxity: A pilot study
Background Recently, macro-focused ultrasound (MFU) has become a popular noninvasive esthetic treatment for facial laxity. However, there are no studies done that evaluated the use of MFU with a 2.0 mm transducer for upper facial lifting. Aims To evaluate the efficacy and safety of MFU with a 2.0 mm transducer in the treatment of upper facial laxity in Thai patients. Methods This was a prospective, evaluator-blinded pilot study with 34 Thai patients diagnosed with mild to moderate facial laxity. Patients were treated with a single session of MFU with 2.0 mm transducer at the forehead, lateral and just below the eye area. Primary outcome was the clinical improvement of upper facial laxity graded by 2 blinded dermatologists at baseline, 1-week, 1-, 3-, and 6-month follow-up. Objective measurements including eyebrow height, upper facial volume, and textural irregularities were evaluated. Patients' self-assessment scores and adverse effects were also recorded. Results Out of 34 patients, 27 (79.4%) attended all follow-ups. Clinical improvement of upper facial laxity was observed as early as 1-week follow-up. Eyebrow height elevation was significantly increased at every follow-up (P = .000) with an average of 1.22 mm at 6-month follow-up. Wrinkles improved significantly at 1-week and 6-month follow-up (P = .002 andP = .010, respectively). Skin roughness showed significant improvement at 6-month follow-up (P = .004). Majority of the patients (53.6%) reported marked improvement at 3-month follow-up. No serious adverse event was noted. Conclusion Macro-focused ultrasound is a safe and effective treatment for upper facial laxity and skin textural irregularities in patients with mild to moderate degree of laxity.
- 1 August 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (8) , 1955-1961
The efficacy of macro-focused ultrasound in the treatment of upper facial laxity: A pilot study
Background Recently, macro-focused ultrasound (MFU) has become a popular noninvasive esthetic treatment for facial laxity. However, there are no studies done that evaluated the use of MFU with a 2.0 mm transducer for upper facial lifting. Aims To evaluate the efficacy and safety of MFU with a 2.0 mm transducer in the treatment of upper facial laxity in Thai patients. Methods This was a prospective, evaluator-blinded pilot study with 34 Thai patients diagnosed with mild to moderate facial laxity. Patients were treated with a single session of MFU with 2.0 mm transducer at the forehead, lateral and just below the eye area. Primary outcome was the clinical improvement of upper facial laxity graded by 2 blinded dermatologists at baseline, 1-week, 1-, 3-, and 6-month follow-up. Objective measurements including eyebrow height, upper facial volume, and textural irregularities were evaluated. Patients' self-assessment scores and adverse effects were also recorded. Results Out of 34 patients, 27 (79.4%) attended all follow-ups. Clinical improvement of upper facial laxity was observed as early as 1-week follow-up. Eyebrow height elevation was significantly increased at every follow-up (P = .000) with an average of 1.22 mm at 6-month follow-up. Wrinkles improved significantly at 1-week and 6-month follow-up (P = .002 andP = .010, respectively). Skin roughness showed significant improvement at 6-month follow-up (P = .004). Majority of the patients (53.6%) reported marked improvement at 3-month follow-up. No serious adverse event was noted. Conclusion Macro-focused ultrasound is a safe and effective treatment for upper facial laxity and skin textural irregularities in patients with mild to moderate degree of laxity.
- 10 July 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (9) , 2288-2294
Efficacy of home‐use light‐emitting diode device at 637 and 854‐nm for facial rejuvenation: A split‐face pilot study
Background: The use of light‐emitting diode (LED) in combination wavelength for facial rejuvenation has been previously reported. Nowadays, there has been a growing market for home‐use cosmetic devices because of its low cost and convenience.Aims: To evaluate the efficacy and safety of home‐use LED device on facial rejuvenation.Methods: This was a prospective split‐face clinical trial with a total of 24 subjects, who presented with photo aging skin. All subjects were treated with the home‐use LED device on the left side of their face, twice a week for 8 weeks. Primary outcomes measured in the study were the changes in the biophysical properties of the skin assessed with the following parameters: skin elasticity, skin hydration, texture, and wrinkles. Evaluations were done at baseline, 2‐, 4‐, 6‐, and 8‐week follow‐up. Subjects’ self‐improvement scores and adverse reactions were also recorded.Results: All 24 subjects completed the study and attended all follow‐up. Skin elasticity was significantly higher in the LED group compared to the control during the 6‐ and 8‐week follow‐up (P < .05). In the LED group, an image of the treated skin captured using Visioscan® showed improvement of the skin texture at 8‐week follow‐up. Majority of the subjects in the LED group scored good improvement on all follow‐ups (37.5%, 41.7%, 58.3%, and 62.5%) when compared to the baseline. No adverse reactions or pain were recorded in the study.Conclusion: The home‐use LED device, with a combination wavelength of 637 and 854 nm, is safe and can be used as an adjunctive treatment for self‐administered facial rejuvenation.
- 10 July 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (9) , 2288-2294
Efficacy of home‐use light‐emitting diode device at 637 and 854‐nm for facial rejuvenation: A split‐face pilot study
Background: The use of light‐emitting diode (LED) in combination wavelength for facial rejuvenation has been previously reported. Nowadays, there has been a growing market for home‐use cosmetic devices because of its low cost and convenience.Aims: To evaluate the efficacy and safety of home‐use LED device on facial rejuvenation.Methods: This was a prospective split‐face clinical trial with a total of 24 subjects, who presented with photo aging skin. All subjects were treated with the home‐use LED device on the left side of their face, twice a week for 8 weeks. Primary outcomes measured in the study were the changes in the biophysical properties of the skin assessed with the following parameters: skin elasticity, skin hydration, texture, and wrinkles. Evaluations were done at baseline, 2‐, 4‐, 6‐, and 8‐week follow‐up. Subjects’ self‐improvement scores and adverse reactions were also recorded.Results: All 24 subjects completed the study and attended all follow‐up. Skin elasticity was significantly higher in the LED group compared to the control during the 6‐ and 8‐week follow‐up (P < .05). In the LED group, an image of the treated skin captured using Visioscan® showed improvement of the skin texture at 8‐week follow‐up. Majority of the subjects in the LED group scored good improvement on all follow‐ups (37.5%, 41.7%, 58.3%, and 62.5%) when compared to the baseline. No adverse reactions or pain were recorded in the study.Conclusion: The home‐use LED device, with a combination wavelength of 637 and 854 nm, is safe and can be used as an adjunctive treatment for self‐administered facial rejuvenation.
- 3 July 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (8) , 1826-1827
The aftermath of COVID‐19 in dermatology practice: What's next?
The rapidly increasing number of COVID‐19‐infected patients and evidence of human‐to‐human transmission even within the asymptomatic incubation period prompted the attention of the entire world. The field of dermatology and procedural dermatology is not exempt from this global issue. We cannot deny the fact that this situation will have a lasting impact on the health‐seeking behaviors of our patients. It is necessary for dermatologists and dermatologic surgeons to be aware of the potential risks and precautions when re‐emerging their practices after COVID‐19.
- 3 July 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (8) , 1826-1827
The aftermath of COVID‐19 in dermatology practice: What's next?
The rapidly increasing number of COVID‐19‐infected patients and evidence of human‐to‐human transmission even within the asymptomatic incubation period prompted the attention of the entire world. The field of dermatology and procedural dermatology is not exempt from this global issue. We cannot deny the fact that this situation will have a lasting impact on the health‐seeking behaviors of our patients. It is necessary for dermatologists and dermatologic surgeons to be aware of the potential risks and precautions when re‐emerging their practices after COVID‐19.
- Open Access
- 16 May 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1636-1641
The efficacy and safety of fractional radiofrequency nanoneedle system in the treatment of atrophic acne scars in Asians
Background: Multiple treatment modalities have been developed to treat atrophic acne scars with varying degrees of success. Post‐inflammatory hyperpigmentation (PIH) after acne scar treatments remain a major concern in Asian patients. Fractional radiofrequency (FRF) has been used in many dermatological skin conditions including acne scars.Aims: To determine the efficacy and safety of FRF nanoneedle system in the treatment of acne scars in Asians.Methods: This is a prospective, evaluator‐blinded study with 25 subjects diagnosed with moderate to severe acne scarring. All subjects received 3 monthly treatments of the FRF nanoneedle system on both cheeks. Primary outcome was the clinical improvement of acne scars graded by 2 blinded dermatologists at baseline, 1‐, 3‐, and 6‐month follow‐ups. Objective scar volume analysis was done using ultraviolet A (UVA) light video camera. Subjects’ self‐assessment, pain score, and adverse events were also recorded.Results: Twenty‐three out of 25 subjects completed the study and attended all follow‐up. Clinical improvement of acne scars was observed as early as 1‐month follow‐up. Objective evaluation of acne scar volume decreased significantly on all follow‐up compared to baseline (P < .005). Majority of the subjects (48%) reported marked improvement in their acne scars. Adverse events such as pain, erythema, burning sensation, edema, scab formation, and PIH were mild and temporary.Conclusions: FRF nanoneedle system is a safe and effective treatment for acne scars in Asians. However, despite the significant changes in the scar volume, caution should be used to avoid excessive coagulation resulting in PIH.
- 16 May 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1636-1641
Open AccessThe efficacy and safety of fractional radiofrequency nanoneedle system in the treatment of atrophic acne scars in Asians
Background: Multiple treatment modalities have been developed to treat atrophic acne scars with varying degrees of success. Post‐inflammatory hyperpigmentation (PIH) after acne scar treatments remain a major concern in Asian patients. Fractional radiofrequency (FRF) has been used in many dermatological skin conditions including acne scars.Aims: To determine the efficacy and safety of FRF nanoneedle system in the treatment of acne scars in Asians.Methods: This is a prospective, evaluator‐blinded study with 25 subjects diagnosed with moderate to severe acne scarring. All subjects received 3 monthly treatments of the FRF nanoneedle system on both cheeks. Primary outcome was the clinical improvement of acne scars graded by 2 blinded dermatologists at baseline, 1‐, 3‐, and 6‐month follow‐ups. Objective scar volume analysis was done using ultraviolet A (UVA) light video camera. Subjects’ self‐assessment, pain score, and adverse events were also recorded.Results: Twenty‐three out of 25 subjects completed the study and attended all follow‐up. Clinical improvement of acne scars was observed as early as 1‐month follow‐up. Objective evaluation of acne scar volume decreased significantly on all follow‐up compared to baseline (P < .005). Majority of the subjects (48%) reported marked improvement in their acne scars. Adverse events such as pain, erythema, burning sensation, edema, scab formation, and PIH were mild and temporary.Conclusions: FRF nanoneedle system is a safe and effective treatment for acne scars in Asians. However, despite the significant changes in the scar volume, caution should be used to avoid excessive coagulation resulting in PIH.
- 25 April 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1662-1666
Efficacy of olive leaf extract–containing cream for facial rejuvenation: A pilot study
Background: Olive leaf extract (OLE), a naturally extracted product from olive leaves, contains oleuropein and other bioactive phenolic compounds. Oleuropein was identified to have various medical properties. It was also found to inhibit the effects of both acute and chronic UVB‐induced skin damage as well as accelerate wound healing activity.Aims: To evaluate the efficacy of olive leaf extract–containing cream on facial rejuvenation.Methods: This is a prospective pilot study with a total of 36 participants, who presented with photoaging skin. All participants applied the olive leaf extract–containing cream (SUPERHEAL™ O‐Live Cream, PhytoCeuticals, Inc, USA) to their whole face twice daily for 2 months. Primary outcomes measured in the study were the changes in the biophysical properties of the skin assessed with the following parameters: melanin and erythema index, transepidermal water loss (TEWL), skin hydration, skin pH, sebum level, texture, and wrinkles.Results: After 2 months, TEWL decreased significantly (P = .007) and maintained the results 1 month after discontinuation of the treatment (P = .007). Skin hydration also increased significantly after 2 months (P = .004). Wrinkles improved significantly on all follow‐ups (P < .001, P = .001, P = .001, respectively). An image of the skin captured using Visioscan® showed improvement of the skin texture 2 months after treatment. Majority of the participants (64%) noted improvement in their skin texture.Conclusion: Olive leaf extract–containing cream provided benefits on skin rejuvenation in human skin.
- 25 April 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1662-1666
Efficacy of olive leaf extract–containing cream for facial rejuvenation: A pilot study
Background: Olive leaf extract (OLE), a naturally extracted product from olive leaves, contains oleuropein and other bioactive phenolic compounds. Oleuropein was identified to have various medical properties. It was also found to inhibit the effects of both acute and chronic UVB‐induced skin damage as well as accelerate wound healing activity.Aims: To evaluate the efficacy of olive leaf extract–containing cream on facial rejuvenation.Methods: This is a prospective pilot study with a total of 36 participants, who presented with photoaging skin. All participants applied the olive leaf extract–containing cream (SUPERHEAL™ O‐Live Cream, PhytoCeuticals, Inc, USA) to their whole face twice daily for 2 months. Primary outcomes measured in the study were the changes in the biophysical properties of the skin assessed with the following parameters: melanin and erythema index, transepidermal water loss (TEWL), skin hydration, skin pH, sebum level, texture, and wrinkles.Results: After 2 months, TEWL decreased significantly (P = .007) and maintained the results 1 month after discontinuation of the treatment (P = .007). Skin hydration also increased significantly after 2 months (P = .004). Wrinkles improved significantly on all follow‐ups (P < .001, P = .001, P = .001, respectively). An image of the skin captured using Visioscan® showed improvement of the skin texture 2 months after treatment. Majority of the participants (64%) noted improvement in their skin texture.Conclusion: Olive leaf extract–containing cream provided benefits on skin rejuvenation in human skin.